Latest Breaking News On - Pharma limited nasdaq - Page 8 : comparemela.com

OKYO Pharma Announces PDMR Dealing

OKYO Pharma Announces PDMR Dealing | MarketScreener

LONDON and NEW YORK, March 24, 2023 OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant. | March 24, 2023

Investegate |OKYO Pharma Limited Announcements | OKYO Pharma Limited: Director/PDMR Dealings

Investegate announcements from OKYO Pharma Limited, Director/PDMR Dealings

OKYO Pharma (OKYO) Prices $5.74M Private Placement

OKYO Pharma LTD: OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER